Zoetis has announced the acquisition of veterinary teleradiology services provider VitalRads from Thrive Pet Healthcare. This strategic move expands the company's diagnostic and digital service capabilities within the veterinary market.
A law firm is reminding investors of the upcoming deadline to serve as lead plaintiff in a securities fraud lawsuit against Zoetis. This legal action could impact the company's reputation and financial standing regarding its disclosures during the specified period.
A securities fraud class action lawsuit has been filed against Zoetis regarding alleged misstatements about product adoption. Investors have until July 27, 2026, to seek lead plaintiff status in the litigation.
Zoetis has officially launched Lenivia, a long-acting monoclonal antibody therapy for canine osteoarthritis, in Canada and the European Union. This product expansion provides a new revenue stream and strengthens the company's portfolio in animal pain management.
Headlines surfaced and scored by PortcoMonitor. Get the full, ranked feed + a daily briefing →